Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Stem Cell Therapy Sector – Market Size, Opportunities, News, Region of Operations, Advancement, Manufacturer’s like Aastrom Biosciences Inc., Advanced Cell Technologies, Inc., Athersys Inc., Celgene Corporation, Cellular Dynamics International, Cytori Therapeutics, Inc., Fibrocell & Strategies Forecasted to 2025

Friday, March 17, 2017 4:41
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Stem cell therapy is the use of stem cells for treatment or prevention of diseases.

Research activities are conducted worldwide for development of stem cell treatments for heart diseases, diabetes, and others.

It is majorly used for the treatment of cancer, to study effects on neuronal degeneration, multiple sclerosis, spinal cord injury, and others.

Mode of Therapy is subsegmented into

·      Allogeneic

·      Autologous stem cell therapy.

Inquire About Report:

Ongoing R&D activities and novel techniques are expected to foster the growth of the market in the coming years.

The Global Stem Cell Therapy Market is segmented based on Mode Of Therapy, Therapeutic Applications, and Geography.

Rise in funding, development of advanced genomic methods, increase in focus on human embryonic stem cells, and surge in approvals of clinical trials for stem cells therapy drive the growth of the global stem cell therapy market.

On the basis of Therapeutic Applications, the market is divided into

·      Eye Diseases,

·      GIT Diseases,

·      Metabolic Diseases,

·      Immune System Diseases,

·      Musculoskeletal Disorders,

·      CNS Diseases,

·      Wounds & Injuries, and others.

Speak to Analyst:

However, lack of required infrastructure, difficulties related with the preservation of stem cells, ethical issues, immunorejection after stem cell transplantation, complexity involved in identification of stem cells in adult tissues limit the market growth.

Geographically, the market is segmented into

·      North America

·      Asia-Pacific

·      Europe

·      LAMEA

Lack of effective treatments to cure diseases, evolution of new stem cell therapies, and emergence of induced pluripotent stem (IPS) cells as an alternative to ESCS are anticipated to create opportunities in the industry.

Key players profiled in the report are

·      Aastrom Biosciences Inc.

·      Advanced Cell Technologies Inc.

·      Athersys Inc.

·      Celgene Corporation

·      Cellular Dynamics International

·      Cytori Therapeutics, Inc.

·      Fibrocell Science, Inc., and others.

They have adopted various strategies, such as mergers & acquisition, expansions, new product launches, joint ventures, collaborations, partnerships, and others to strengthen their foothold in the global market.

Check Discount for Full Report:


About Company
The company was found with an initiative to bridge the gap between enterprises and global opportunities. It is driven by the sole motive to build an effective channel to communicate up-to-date qualitative and quantitative market intelligence with all-scale participants.

Reach Us
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int’l:       +1-971-202-1575
Toll Free:   ++ 1-800-910-6452
Fax:   +1-800-792-5285

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.